Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00225

Submission Number:
00225
Commenter:
mike hamik
State:
Nebraska
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
DIR fees will put ALL independent pharmacies out of business soon. Please help us stay in business. DIR fees are completely unfair to the retailer. Thank You Mike Hamik